Structure/function studies of hepatocyte nuclear factor-1α, a diabetes-associated transcription factor

被引:30
|
作者
Yang, Q
Yamagata, K
Yamamoto, K
Miyagawa, J
Takeda, J
Iwasaki, N
Iwahashi, H
Yoshiuchi, I
Namba, M
Miyazaki, J
Hanafusa, T
Matsuzawa, Y
机构
[1] Osaka Univ, Grad Sch Med, Dept Internal Med & Mol Sci, Suita, Osaka 5650871, Japan
[2] Osaka Univ, Grad Sch Med, Dept Gen Med, Suita, Osaka 5650871, Japan
[3] Osaka Univ, Grad Sch Med, Dept Nutr & Physiol Chem, Suita, Osaka 5650871, Japan
[4] Gunma Univ, Inst Mol & Cellular Regulat, Dept Cell Biol, Genet Mol Lab, Maebashi, Gumma 3718512, Japan
[5] Tokyo Womens Med Univ, Ctr Diabet, Tokyo 1628666, Japan
基金
日本学术振兴会;
关键词
diabetes mellitus; MODY; HNF-1; alpha;
D O I
10.1006/bbrc.1999.1747
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mutations in the transcription factor hepatocyte nuclear factor-1 alpha (HNF-1 alpha) cause maturity-onset diabetes of the young type 3 (MODY3), a form of diabetes mellitus characterized by autosomal dominant inheritance, early onset, and pancreatic beta-cell dysfunction. me have examined the effects of five diabetes-associated mutations (L12H, G191D, R263C, P379fsdelCT, and L584S585fsinsTC) on HNF-1 alpha function including DNA binding ability, intracellular localization, and transactivation activity. L12H, P379fsdelCT, and L584S585fsinsTC mutations were found in patients with a clinical diagnosis of MODY, while G191D and R263C mutations were identified in patients diagnosed with type 2 diabetes. These mutations had diverse effects on the functional properties of HNF-1 alpha. Comparison of the functional data with clinical information suggested that transactivation activity of mutant HNF-1 alpha in beta cells like MIN6 may be the primary determinants of the phenotypic differences observed among diabetic patients with HNF-1 alpha mutations. (C) 1999 Academic Press.
引用
收藏
页码:196 / 202
页数:7
相关论文
共 50 条
  • [1] Abnormal nephron development associated with a frameshift mutation in the transcription factor hepatocyte nuclear factor-1β
    Bingham, C
    Ellard, S
    Allen, L
    Bulman, M
    Shepherd, M
    Frayling, T
    Berry, PJ
    Clark, PM
    Lindner, T
    Bell, GI
    Ryffel, GU
    Nicholls, AJ
    Hattersley, AT
    KIDNEY INTERNATIONAL, 2000, 57 (03) : 898 - 907
  • [2] Contrasting diabetes phenotypes associated with hepatocyte nuclear factor-1α and -1β mutations
    Pearson, ER
    Badman, MK
    Lockwood, CR
    Clark, PM
    Ellard, S
    Bingham, C
    Hattersley, AT
    DIABETES CARE, 2004, 27 (05) : 1102 - 1107
  • [3] Diabetes-associated sustained activation of the transcription factor nuclear factor-κB
    Bierhaus, A
    Schiekofer, S
    Schwaninger, M
    Andrassy, M
    Humpert, PM
    Chen, J
    Hong, M
    Luther, T
    Henle, T
    Klöting, I
    Morcos, M
    Hofmann, M
    Tritschler, H
    Weigle, B
    Kasper, M
    Smith, M
    Perry, G
    Schmidt, AM
    Stern, DM
    Häring, HU
    Schleicher, E
    Nawroth, PP
    DIABETES, 2001, 50 (12) : 2792 - 2808
  • [4] Role of transcription factor hepatocyte nuclear factor-1β in polycystic kidney disease
    Shao, Annie
    Chan, Siu Chiu
    Igarashi, Peter
    CELLULAR SIGNALLING, 2020, 71
  • [5] Transcription Factor Hepatocyte Nuclear Factor-1β Regulates Renal Cholesterol Metabolism
    Aboudehen, Karam
    Kim, Min Soo
    Mitsche, Matthew
    Garland, Kristina
    Anderson, Norma
    Noureddine, Lama
    Pontoglio, Marco
    Patel, Vishal
    Xie, Yang
    DeBose-Boyd, Russell
    Igarashi, Peter
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 27 (08): : 2408 - 2421
  • [6] Hepatocyte nuclear factor-1α gene mutations and diabetes in Norway
    Bjorkhaug, L
    Sagen, JV
    Thorsby, P
    Sovik, O
    Molven, A
    Njolstad, PR
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (02): : 920 - 931
  • [7] Hepatocyte nuclear factor-1 alpha regulates transcription of the guanylin gene
    Hochman, JA
    Sciaky, D
    Whitaker, TL
    Hawkins, JA
    Cohen, MB
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 1997, 273 (04): : G833 - G841
  • [8] Clinical spectrum associated with hepatocyte nuclear factor-1β mutations
    Bellanné-Chantelot, C
    Chauveau, D
    Gautier, JF
    Dubois-Laforgue, D
    Clauin, S
    Beaufils, S
    Wilhelm, JM
    Boitard, C
    Noël, LH
    Velho, G
    Timsit, J
    ANNALS OF INTERNAL MEDICINE, 2004, 140 (07) : 510 - 517
  • [9] Expression ratio of hepatocyte nuclear factor-1 to variant hepatocyte nuclear factor-1 in differentiation of hepatocellular carcinoma and hepatoblastoma
    Ninomiya, T
    Hayashi, Y
    Saijoh, K
    Ohta, K
    Yoon, S
    Nakabayashi, H
    Tamaoki, T
    Kasuga, M
    Itoh, H
    JOURNAL OF HEPATOLOGY, 1996, 25 (04) : 445 - 453
  • [10] Positive regulation of connexin32 transcription by hepatocyte nuclear factor-1α
    Koffler, LD
    Fernstrom, MJ
    Akiyama, TE
    Gonzalez, FJ
    Ruch, RJ
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2002, 407 (02) : 160 - 167